Scientists have long suspected dopamine plays a key role in addiction. Now, they’re putting it under the microscope.
The receptor no one was watching Dopamine works by attaching to receptors on brain cells, like a key fitting into a lock. One of the most important is the D2 receptor. In people with substance use disorders, these receptors often become less available. It’s as if the brain removes the locks, so the key can’t work. Preclinical studies in animals show opioid use reduces D2 receptors and disrupts dopamine transporters. But human data has been mixed.
Now, researchers are pulling all the human brain scan studies together to see the full picture. They’re focusing on two types of imaging: PET and SPECT scans. These tools let scientists measure how much dopamine activity exists in the brain. The goal is to find clear patterns in people with OUD compared to those without.
A switch that burns out Think of the dopamine system like a car engine. In a healthy brain, the engine idles smoothly. You feel motivated when needed, calm when resting. But in OUD, it’s like the engine is stuck in neutral. Even when you press the gas (try to feel joy from food, hobbies, or people), nothing happens. The brain has downregulated its response. This may explain anhedonia—the inability to feel pleasure—and why cravings can feel so urgent.
What changed after six months The new review will analyze data from adults diagnosed with OUD who underwent brain scans. Researchers will look at measures like D2/D3 receptor availability and dopamine transporter (DAT) levels. They’ll compare them to healthy controls. The analysis will also consider factors like how long someone has been abstinent, which could affect results.
Early findings from past studies suggest people with OUD tend to have lower D2 receptor availability. This change may not reverse quickly, even after stopping opioid use. That could help explain why recovery is so hard. The brain’s reward system stays dull, making relapse more likely.
But there's a catch. Not all studies agree. Some show big differences. Others show little. This could be due to different methods, types of scanners, or how long people had been using opioids. The new review aims to make sense of these differences by using strict criteria and statistical tools to combine results.
This doesn't mean this treatment is available yet.
Why memory held up longer Experts say understanding dopamine’s role could shift how we treat OUD. Most current medications target the opioid system, especially the μ-opioid receptor. They help reduce withdrawal and cravings. But they don’t fix the underlying dopamine imbalance. New treatments could aim at dopamine directly, such as drugs that target D3 receptors or modulate the κ-opioid system, which influences dopamine release.
These approaches are still in early stages. But they represent a shift—from managing symptoms to repairing brain function.
What this means for patients is not immediate change, but future hope. No new drug will emerge overnight. But this review could help prioritize which targets are most promising for drug development. It may also help explain to patients that their struggle isn’t moral failure. It’s biology.
But the science has limits. The review will only include published studies with certain methods. It won’t prove cause and effect. Just because dopamine levels are low doesn’t mean that caused the addiction. It could be a result, or both could stem from another factor. Also, most data comes from small studies. The brain is complex, and one system doesn’t tell the whole story.
Still, this is the first effort to bring all the human imaging data together in a structured way. By clarifying what’s happening in the brain, it could guide better treatments for the millions still searching for lasting recovery.
The road ahead includes testing new medications that work outside the opioid system. Some are already in early trials. How long it takes to get new options to patients depends on funding, trial results, and safety. Brain science moves slowly. But each step forward helps us see addiction not as a choice, but as a condition that changes the brain—and one that may one day be repaired.
